| Date Filed | Type | Description |
| 01/04/2022 |
4
| MACALUSO MICHAEL (Director) has filed a Form 4 on Ampio Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 68,400 shares
@ $0.57, valued at
$39k
|
|
| 10/28/2021 |
4
| MACALUSO MICHAEL (CEO) has filed a Form 4 on Ampio Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 43,470 shares
@ $1.64, valued at
$71.3k
|
|
| 10/13/2021 |
4
| MACALUSO MICHAEL (CEO) has filed a Form 4 on Ampio Pharmaceuticals, Inc.|
Txns:
| Granted 950,000 shares
@ $0 |
|
| 04/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/21/2020 |
4
| MACALUSO MICHAEL (CEO) has filed a Form 4 on Ampio Pharmaceuticals, Inc.|
Txns:
| Granted 50,000 options to buy
@ $1.78, valued at
$89k
|
|
| 07/06/2020 |
4
| MACALUSO MICHAEL (CEO) has filed a Form 4 on Ampio Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 220,000 options to buy
@ $1.03, valued at
$226.6k
Disposed/sold 80,000 options to buy
@ $1.7, valued at
$136k
Granted 255,000 options to buy
@ $0.65, valued at
$165.8k
|
|
| 06/12/2020 |
4
| MACALUSO MICHAEL (Director) has filed a Form 4 on AYTU BIOSCIENCE, INC|
Txns:
| Granted 40,000 options to buy
@ $1.45, valued at
$58k
|
|
| 01/14/2020 |
4
| MACALUSO MICHAEL (CEO) has filed a Form 4 on Ampio Pharmaceuticals, Inc.|
Txns:
| Granted 200,000 options to buy
@ $0.6779, valued at
$135.6k
|
|
| 10/26/2018 |
4
| MACALUSO MICHAEL (Director) has filed a Form 4 on AYTU BIOSCIENCE, INC|
Txns:
| Granted 200,000 shares
@ $0 |
|
| 11/09/2017 |
4
| MACALUSO MICHAEL (Director) has filed a Form 4 on AYTU BIOSCIENCE, INC|
Txns:
| Granted 50,000 shares
@ $0 |
|
| 03/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/13/2017 |
4
| MACALUSO MICHAEL (CEO) has filed a Form 4 on Ampio Pharmaceuticals, Inc. |
| 04/13/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/03/2013 |
4
| MACALUSO MICHAEL (CEO) has filed a Form 4 on Ampio Pharmaceuticals, Inc. |
| 02/14/2012 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 01/17/2012 |
4
| MACALUSO MICHAEL (CEO) has filed a Form 4 on Ampio Pharmaceuticals, Inc. |
| 09/27/2011 |
3
| MACALUSO MICHAEL (Director) has filed a Form 3 on Ampio Pharmaceuticals, Inc. |
| 02/14/2005 |
5
| Form 5 -- Annual statement of changes in beneficial ownership of securities |
| 01/29/2004 |
5
| MACALUSO MICHAEL (CEO and President) has filed a Form 5 on ISOLAGEN INC |